Hematocrit Test Market Research Report- Forecast till 2027

Hematocrit Test Market Research Report: Information By Product (Analyzer, Hematocrit Test Meter), Indication (Anemia, Leukemia, Lymphoma, Congenital Heart Disease, Kidney Tumor), End-User (Hospital, Clinic, Diagnostic Center) – Global Forecast Till 2027

ID: MRFR/LS/4105-HCR | February 2021 | Region: Global | 110 pages

Please note that the assessment period of report has been updated from 2017-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Synopsis of the Global Hematocrit Test Market


Also known as packed-cell volume (PCV) test, hematocrit test is used to measure the percentage of Red Blood Cells (RBCs) in the blood. The major function of the RBCs is to carry blood throughout the body. The test is usually performed to diagnose various diseases such as anemia, leukemia, lymphoma, congenital heart disease, and others. The test determines the elevation in the percentage of normal RBCs which is 38.8%-50% in men and 34.9%-44.5% in women. The hematocrit test is one of the tests included under complete blood count (CBC) test.


Cardiovascular diseases, cancer, and kidney diseases are increasing the economic burden of various developing and developed nations across the globe. The market for hematocrit test is driven by rising prevalence of chronic diseases such as cardiovascular diseases, diabetes, and others along with changing lifestyle, and increasing demand for diagnostic devices for cardiovascular diseases. However, limited number of trained personnel has restrained the growth of the market. However, the high cost of diagnosis and treatment of cardiovascular diseases also restrains the growth of the market. As per the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the overall prevalence of Chronic Kidney Disease (CKD) in the general population across the globe is nearly 14%. However, the growth of the market is restrained by the inaccurate or misleading result of the test and unawareness about hematocrit test in the diagnosis of the disease.


The global hematocrit test market is expected to grow at a CAGR of 4.5% during the forecast period.


FIGURE 1: Global Hematocrit Test Market by Type, 2016 (%)


 Hematocrit Test Market


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


Segments  


The global hematocrit test market is segmented on the basis of product, indication, devices, and end-user.


On the basis of product, the market is segmented into the analyzer, hematocrit test meter, and others.


On the basis of indication, the market is segmented into anemia, leukemia, lymphoma, congenital heart disease, kidney tumor, and others.


On the basis of the end-user, the market is segmented into hospitals & clinics, diagnostic centers, and others.


Intended Audience



  • Medical Device Manufacturers

  • Medical Device Suppliers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors


Research Methodology


 Hematocrit Test Market Research Methodology


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


Regional Analysis of the Global Hematocrit Test Market                      

The global hematocrit test market consists of four major regions namely, the Americas, Europe, Asia Pacific and the Middle East & Africa, with the Americas capturing the largest market share. The growth of the market is attributed to an increase in the demand for diagnostic procedures, and rising importance of hematology testing for the diagnosis of various chronic diseases. North America accounts for the major share in the American hematocrit test market which is attributed to extensive use of hematocrit test with other diagnostic tests. According to the Center for the Disease Control and Prevention (CDC), as of 2012, nearly half of all the adults, 117 million population in the U.S. had one or more chronic health conditions. One in four adults were diagnosed with two or more chronic health diseases.

In Europe, the growth of the market is driven by increasing demand for diagnostic devices and instrument in hospitals and diagnostic centers. Germany, the U.K, and France are the major contributors to the growth of the market owing to an increase in the number of key players engaged in the manufacturing of medical devices and instruments and rising expenditure in research and development by these major economies. Additionally, well-developed healthcare sector, ever-increasing patient population and high healthcare expenditure by the European nations fuel the market growth.

The Asia Pacific is expecting the fastest growth in the market due to the flourishing growth of healthcare industries in developing economies such as India. Additionally, the ever-increasing prevalence of kidney diseases and cardiovascular diseases and rising demand for quality devices in the healthcare sector is expected to lead the use of advanced equipment, which, in turn, may speed up the market growth in the region. Rising geriatric population with chronic diseases further creates the economic burden on the developing nations thereby accelerating the market growth.

The Middle East & Africa hold the least share in the market. The market in this regions exhibits steady growth owing to an increase in the demand for the diagnostic and treatment services.  In the Middle East and Africa, the United Arab Emirates (UAE) hold the largest market share owing to the availability of diagnostic and treatment services. Africa shows slow growth due to low technology penetration in developing countries.

Key Players in the Global Hematocrit Test Market         

Some of the key players in this market are Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Siemens AG (Germany), Beckman Coulter, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Horiba, Ltd. (Japan), Mindray Medical International Limited (China), Boule Diagnostics AB (Sweden), Nihon Kohden Corporation (Japan), Sysmex Corporation (Japan), and others.



Frequently Asked Questions (FAQ) :


Hematocrit tests are used to measure the percentage of red blood cells in the body.

The market is expected to exhibit a strong 4.5% CAGR over the forecast period from 2017 to 2023.

Growing awareness about hematological diseases is the major driver for the hematocrit test market.

The Americas dominate the Global Hematocrit Test Market, followed by Europe

Leading players in the hematocrit test market include Abbott, Siemens AG, and Beckman Coulter, among others.

Table of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. Global Hematocrit Test Market, by Product

6.1 Introduction

6.2 Analyzer

6.2.1 Market Estimates & Forecast, 2020-2027

6.3 Hematocrit Test Meter

6.3.1 Market Estimates & Forecast, 2020-2027

6.4 Others

6.4.1 Market Estimates & Forecast, 2020-2027

7. Global Hematocrit Test Market, by Indication

7.1 Introduction

7.2 Anemia

7.2.1 Market Estimates & Forecast, 2020-2027

7.3 Leukemia

7.3.1 Market Estimates & Forecast, 2020-2027

7.4 Lymphoma

7.4.1 Market Estimates & Forecast, 2020-2027

7.5 Kidney Transplant

7.5.1 Market Estimates & Forecast, 2020-2027

7.6 Kidney Tumor

7.6.1 Market Estimates & Forecast, 2020-2027

7.7 Others

7.7.1 Market Estimates & Forecast, 2020-2027

8. Global Hematocrit Test Market, by End User

8.1 Introduction

8.2 Hospitals & Clinics

8.2.1 Market Estimates & Forecast, 2020-2027

8.3 Tertiary Care Centers

8.3.1 Market Estimates & Forecast, 2020-2027

8.4 Others

8.4.1 Market Estimates & Forecast, 2020-2027

9. Global Hematocrit Test Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 U.S.

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 U.K

9.3.1.4 Italy

9.3.1.5 Spain

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic of Korea

9.4.6 Rest of Asia Pacific

9.5 The Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Kuwait

9.5.5 Qatar

9.5.6 Rest of the Middle East & Africa

10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

11 Company Profiles

11.1 Abbott

11.1.1 Company Overview

11.1.2 Indication Overview

11.1.3 Financials

11.2 F. Hoffmann-La Roche Ltd

11.2.1 Company Overview

11.2.2 Indication Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.3 Siemens AG

11.3.1 Company Overview

11.3.2 Indication Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.4 Beckman Coulter, Inc.

11.4.1 Company Overview

11.4.2 Indication/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.5 Bio-Rad Laboratories, Inc.

11.5.1 Company Overview

11.5.2 Indication Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.6 Nihon Kohden Corporation

11.6.1 Overview

11.6.2 Indication Overview

11.6.3 Financials

11.6.4 Key Developments

11.7 Sysmex Corporation

11.7.1 Overview

11.7.2 Indication Overview

11.7.3 Financials

11.7.4 Key Developments

11.8 Boule Diagnostics AB

11.8.1 Overview

11.8.2 Indication Overview

11.8.3 Financials

11.8.4 Key Developments

11.9 Others

12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Medical Device Industry

13 Appendix

LIST OF TABLES

Table 1 Hematocrit Test Industry Synopsis, 2020-2027

Table 2 Global Hematocrit Test Market Estimates and Forecast, 2020-2027, (USD Million)

Table 3 Global Hematocrit Test Market by Region, 2020-2027, (USD Million)

Table 4 Global Hematocrit Test Market by Products, 2020-2027, (USD Million)

Table 5 Global Hematocrit Test Market by Indication, 2020-2027, (USD Million)

Table 7 Global Hematocrit Test Market by End Users, 2020-2027, (USD Million)

Table 8 North America Hematocrit Test Market by Products, 2020-2027, (USD Million)

Table 9 North America Hematocrit Test Market by Indication, 2020-2027, (USD Million)

Table 11 North America Hematocrit Test Market by End Users, 2020-2027, (USD Million)

Table 12 U.S. Hematocrit Test Market by Products, 2020-2027, (USD Million)

Table 13 U.S. Hematocrit Test Market by Indication, 2020-2027, (USD Million)

Table 15 U.S. Hematocrit Test Market by End Users, 2020-2027, (USD Million)

Table 16 Canada Hematocrit Test Market by Products, 2020-2027, (USD Million)

Table 17 Canada Hematocrit Test Market by Indication, 2020-2027, (USD Million)

Table 19 Canada Hematocrit Test Market by End Users, 2020-2027, (USD Million)

Table 20 South America Hematocrit Test Market by Products, 2020-2027, (USD Million)

Table 21 South America Hematocrit Test Market by Indication, 2020-2027, (USD Million)

Table 23 South America Hematocrit Test Market by End Users, 2020-2027, (USD Million)

Table 24 Europe Hematocrit Test Market by Products, 2020-2027, (USD Million)

Table 25 Europe Hematocrit Test Market by Indication, 2020-2027, (USD Million)

Table 27 Europe Hematocrit Test Market by End Users, 2020-2027, (USD Million)

Table 28 Western Europe Hematocrit Test Market by Products, 2020-2027, (USD Million)

Table 29 Western Europe Hematocrit Test Market by Indication, 2020-2027, (USD Million)

Table 31 Western Europe Hematocrit Test Market by End Users, 2020-2027, (USD Million)

Table 32 Eastern Europe Hematocrit Test Market by Products, 2020-2027, (USD Million)

Table 33 Eastern Europe Hematocrit Test Market by Indication, 2020-2027, (USD Million)

Table 35 Eastern Europe Hematocrit Test Market by End Users, 2020-2027, (USD Million)

Table 36 Asia Pacific Hematocrit Test Market by Products, 2020-2027, (USD Million)

Table 37 Asia Pacific Hematocrit Test Market by Indication, 2020-2027, (USD Million)

Table 39 Asia Pacific Hematocrit Test Market by End Users, 2020-2027, (USD Million)

Table 40 Middle East & Africa Hematocrit Test Market by Products, 2020-2027, (USD Million)

Table 41 Middle East & Africa Hematocrit Test Market by Indication, 2020-2027, (USD Million)

Table 43 Middle East & Africa Hematocrit Test Market by End Users, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Hematocrit Test Market

Figure 3 Segmentation Market Dynamics for Hematocrit Test Market

Figure 4 Global Hematocrit Test Market Share, by Product, 2020

Figure 5 Global Hematocrit Test Market Share, by Indication, 2020

Figure 6 Global Hematocrit Test Market Share, by End Users, 2020

Figure 7 Global Hematocrit Test Market Share, by Region, 2020

Figure 8 North America Hematocrit Test Market Share, by Country, 2020

Figure 9 Europe Hematocrit Test Market Share, by Country, 2020

Figure 10 Asia Pacific Hematocrit Test Market Share, by Country, 2020

Figure 11 Middle East & Africa Hematocrit Test Market Share, by Country, 2020

Figure 12 Global Hematocrit Test Market: Company Share Analysis, 2020 (%)

Figure 13 Abbott: Key Financials

Figure 14 Abbott: Segmental Revenue

Figure 16 Abbott: Geographical Revenue

Figure 17 F. Hoffmann-La Roche Ltd: Key Financials

Figure 18 F. Hoffmann-La Roche Ltd: Segmental Revenue

Figure 19 F. Hoffmann-La Roche Ltd: Geographical Revenue

Figure 20 Siemens AG: Key Financials

Figure 21 Siemens AG: Segmental Revenue

Figure 22 Siemens AG: Geographical Revenue

Figure 23 Beckman Coulter, Inc.: Key Financials

Figure 24 Beckman Coulter, Inc.: Segmental Revenue

Figure 25 Beckman Coulter, Inc.: Geographical Revenue

Figure 26 Scion Medical Technologies LLC: Key Financials

Figure 27 Scion Medical Technologies LLC: Segmental Revenue

Figure 28 Scion Medical Technologies LLC: Geographical Revenue

Figure 29 Bio-Rad Laboratories, Inc.: Key Financials

Figure 30 Bio-Rad Laboratories, Inc.: Segmental Revenue

Figure 31 Bio-Rad Laboratories, Inc.: Geographical Revenue

Figure 32 Nihon Kohden Corporation: Key Financials

Figure 33 Nihon Kohden Corporation: Segmental Revenue

Figure 34 Nihon Kohden Corporation: Geographical Revenue